Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

RINGER'S INJECTION, LAC

Active
SPE2DP-26-T-4292Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

RINGER'S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per case, is subject to strict packaging and marking requirements mandated by the Department of Defense. Each unit must be sealed in a protective container to prevent damage or breakage, and all shipments must be packed in commercial exterior containers suitable for safe transport via common carrier at the lowest cost to the designated delivery point. Packaging must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all markings must adhere to the latest edition of this standard as published by DLA Troop Support. The product is regulated by the FDA and requires confirmation by a product specialist prior to award, with bidder and manufacturer details submitted through EBS. The item has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C), with brief exposure to up to 40°C permitted without adverse effects. It is prohibited from freezing and must be protected from excessive heat. The contract specifies a quantity of 2 packaging groups, each containing 12 units, for delivery to Dyess AFB within 20 days under FOB destination terms with zero variance allowed. Inspection and acceptance occur at the delivery point, and the item is identified by NSN 6505-01-330-6267 and manufacturer part number NDC00264-7750-00 under B. BRAUN MEDICAL INC. The solicitation, issued under contract SPE2DP-26-T-4292, has an August 3, 2026 response deadline and falls under NAICS code 325412 for pharmaceutical manufacturing.

General Info

RINGER'S INJECTION, LAC contract for two units under DLA solicitation SPE2DP-26-T-4292, deadline August 3, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

220 2ND ST BLDG 7002, DYESS AFB, TX, 79607-1720, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4292.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update
PhaseSolicitation
Posted

Solicitation

Amendment 1

Contract was updated

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Timothy Mccauley
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
RINGER'S INJECTION,LACTATED
RINGER'S INJECTION LACTATED,USP, 1000ML, 12S
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product. RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 PG = 12 EA
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number,
SPE2DP-26-T-4292
SECTION B
and item description. RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
. SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
B. BRAUN MEDICAL INC 11171 P/N L7500 B. BRAUN MEDICAL INC 11171 P/N NDC00264-7750-00
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017617565 0001 PG 2.000
NSN/MATERIAL:6505013306267
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-330-6267 Quantity: 2 PG Purchase Request: 7017618038QTY: 2 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride Injection 0.9% in 250 mL units, packaged 24 bags per purchase group, is being procured under solicitation SPE2DP-26-T-4271 with a delivery requirement of five days FOB destination. The item is regulated by the FDA and must comply with strict packaging and marking standards as defined by Medical Marking Standard No. 1, superseding all references to MIL-STD-129. Each unit must be sealed in commercial-grade containers that protect against damage and breakage, and all exterior shipping containers must ensure safe, cost-effective delivery by common carriers. The product has a non-extendable shelf life of 24 months and must be stored at room temperature with brief exposure to up to 40°C permitted without adverse effect. The item is identified by NSN 6505-01-331-8945 and is subject to zero variance in quantity, with inspection and acceptance occurring at the destination. Multiple manufacturers including B. Braun Medical Inc., ICU Medical Inc., Trillamed LLC, and Cardinal Health 200, LLC are qualified suppliers, each identified by specific NDC numbers and part numbers. All packaging and labeling must conform to the latest Medical Marking Standard No. 1, available through DLA Troop Support, and the solicitation includes requirements for covered defense information. The contracting officer must submit a referral in EBS for product confirmation prior to award, including bidder and manufacturer details.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
ACEPROMAZINE MALEATE IAcepromazine Maleate Injection, Veterinary, is a 10 mg/mL sterile solution in 50 mL vials intended for intramuscular, intravenous, or subcutaneous administration in cats, dogs, and horses, with strict prohibition against use in horses intended for human consumption. The product is supplied in vials as the unit of issue and must be stored at controlled room temperature between 20–25°C (68–77°F). Packaging must comply with the latest Military Medical Marking Standard No. 1B dated 30 March 2017, along with all DLA packaging and technical requirements referenced in the DLA Master List of Technical and Quality Requirements. This item is classified as a Type I (Code Q) shelf-life item with a non-extendable shelf life of 36 months. Suppliers are required to provide Safety Data Sheets (SDS) and Hazard Communication Standard labels in full compliance with OSHA’s 29 C.F.R. 1910.1200, effective June 1, 2015, and must ensure employee training on these requirements. The product is subject to federal acquisition regulations, including the removal of government identification from non-accepted supplies and potential handling of covered defense information. The NSN is 6509011947255, with a purchase quantity of two 50 mL vials under solicitation SPE2DP-26-T-4274, to be delivered FOB destination within 62 days with zero tolerance for quantity variance. Delivery is to APO 09227-0000, and inspection and acceptance occur upon arrival. The manufacturer is Boehringer Ingelheim Animal Health USA, with applicable NDC and part numbers listed, and the contract is managed by the Department of Defense's Medical Supply Chain PHarma FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE TOPICAPOVIDONE-IODINE TOPICAL SOLUTION, USP, is a regulated pharmaceutical product procured under contract SPE2DP-26-T-4280 for U.S. military use, with each unit being a 4 fluid ounce (118 mL) bottle identified by the unit of issue BT and NSN 6505010672812. The product must comply with stringent technical and quality requirements from the DLA Master List, including a mandatory 36-month shelf life, of which at least 31 months must remain at time of delivery to the first government activity. Labeling must conform to MED.MARKING STD 1A, specifying key elements such as manufacturer and CAGE code, manufacturing and expiration dates, contract and lot numbers, and the unit designation 1 BT = 4 OZ. The product is subject to FDA regulation and requires pre-award referral through EBS for validation. Packaging must be commercial-grade, sealed to prevent damage, and shipped in exterior containers ensuring safe transit at minimal cost, adhering to DLA’s packaging directives over ASTM D3951 when applicable, with all marking strictly following MIL-STD-129 despite references to MMS No. 1. The material is classified as non-hazardous per FED-STD-313 and must be shipped by traceable means only, prohibiting parcel post. Two delivery points are specified: Fort Bragg, NC and Fort Bliss, TX, each requiring shipment within 20 days of contract award with no tolerance for quantity variance. Delivery is FOB destination, with inspection and acceptance occurring at the final location. The solicitation lists Cardinal Health 200, LLC and Purdue Pharma LP as potential manufacturers under NDC 67618-0150-04, and procurement is coordinated through DLA Troop Support, with point of contact Shairy M. Cartagena.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENTZinc Oxide Ointment USP, containing 20% zinc oxide in a 28.35 gram collapsible tube, is a topical skin protectant procured under solicitation SPE2DP-26-T-4279 with a requirement for five units of issue. The product must comply with the latest Medical Marking Standard No. 1, be labeled with NDC 67777-0223-11, and be manufactured by Dynarex Corp under part number 1TVZ3. It is subject to a non-extendable shelf life of 36 months as a TYPE I Q-coded item and must be stored at controlled room temperature not exceeding 30°C. Packaging must adhere to DLA Packaging Requirements for Procurement, MIL-STD-129, and ASTM D3951 if non-hazardous, with all markings and labeling controlled by the DLA Master List of Technical and Quality Requirements. The item is regulated by the FDA, requiring referral through EBS for confirmation, and is subject to Covered Defense Information protocols. Delivery is FOB destination within 20 days of contract award, with no variance allowed in quantity, inspection and acceptance occurring at the destination point. The sole delivery address is W51JYU, 0165 CS HHC HHC Combat Sustainment, Bossier City, LA 71111-5397, and shipment must be sent via traceable means, excluding parcel post. The contract specifies a unit price of $5.00 per tube, totaling $25.00, with the original required delivery date set for July 28, 2026. All technical and quality obligations referenced by R-numbers are governed by the DLA Master List in effect on the solicitation issue date, and the product must be palletized in accordance with RP001. Government use only identifiers and tracking codes, including the TCN and SUPP ADD, are included for logistics and accountability purposes, with the contracting office listed as the Department of Defense, Medical Supply Chain PHARM FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
VECURONIUM BROMIDE FORVecuronium Bromide for Injection is a freeze-dried powder containing 10 mg of the active ingredient, supplied in packages of ten vials per unit, with a total shelf life of 24 months. At the time of receipt by the first government activity, the product must have a minimum of 21 months of remaining shelf life, and storage must be maintained at controlled room temperature between 20 to 25°C (68 to 77°F), protected from light and retained in its original carton until use. The item is classified as a Type I (Code M) medical supply with a non-extendable shelf life, and all packaging and marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a protective container and packed in commercial shipping containers ensuring safe delivery at the lowest cost to the specified destination, with strict adherence to hazardous materials shipping protocols. The product, manufactured by Hikma Pharmaceuticals USA Inc., is identified by NDC 00143-9234-10 and NSN 6505-01-258-0983, and is required for delivery to JBER, Alaska, under contract SPE2DP-26-T-4283 with a firm delivery date of July 28, 2026. The procurement specifies a fixed quantity of three units totaling two packages, with no variance permitted, and all shipments must be routed through designated government freight and parcel post addresses. Compliance with DLA packaging, technical, and quality requirements, as outlined in the DLA Master List and supporting directives, is mandatory.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, UThe contract specifies the procurement of Tolnaftate Powder, USP 1%, in 45-gram units, with a total quantity of two BT units, each equivalent to 45 grams, under solicitation SPE2DP-26-T-4282. The item is designated as a Type I (Code Q) medical product with a strict non-extendable shelf life of 36 months, and packaging must comply with commercial standards as outlined in the procurement document, ensuring protection against damage and secure transit via common carrier at the lowest cost to the delivery point. All packaging and labeling must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and includes proper identification and marking requirements for defense-related materials. Delivery is required FOB destination within five days, with no variance permitted in quantity, and inspection and acceptance occur at the destination. The item is sourced from Geri-Care Pharmaceuticals Corp. under NDC57896-0199-45, and the contract mandates compliance with DLA’s Technical and Quality Requirements as defined in the DLA Master List, with applicable provisions for Covered Defense Information. The place of performance is Mountain Home AFB, ID, and the contracting office is the Department of Defense’s Medical Supply Chain Pharm FSA, with point of contact Imerah Burnett.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
TEST STRIPS AND COLORThe contract specifies the procurement of test strips and color charts for urine analysis, detecting bilirubin, blood, glucose, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen. Each unit of issue is a bottle containing 100 strips, and the item is identified by NSN 6550-01-221-5400 with a purchase quantity of four bottles. The product must comply with stringent technical and quality requirements referenced in the DLA Master List, and packaging must adhere to commercial standards as well as the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a protective container, and shipping containers must ensure safe, cost-effective delivery to the specified FPO address. The item is classified as a Type I (Code K) with a non-extendable shelf life of 18 months, and no more than two months may have elapsed between the date of manufacture and the delivery date to the government. All labels must clearly indicate the date of manufacture, expiration or retest date, and the contract or lot number, in accordance with the latest MMS1C guidelines. The solicitation was issued under SPE2DS-26-T-269W with a response deadline of August 3, 2026, and delivery is required within 20 days after award.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
DEXTROSE, POTASSIUM CHLThe contract specifies the procurement of 1000 mL sterile injection solution containing 5 percent dextrose, 0.15 percent potassium chloride, and 0.45 percent sodium chloride, manufactured by Baxter Healthcare Corporation under NDC 00338-0671-04 and part number 2B1654X, packaged in units of 14 per pack (PG), with a total quantity of one unit. The item is regulated by the FDA and subject to strict packaging, marking, and shelf-life requirements; it must have a non-extendable 24-month shelf life and be commercially packaged to protect against damage during transit. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must adhere to DLA’s Master List of Technical and Quality Requirements, which take precedence over other standards such as ASTM D3951. Hazardous material handling protocols under FED-STD-313 and TQ requirement IP025 apply if applicable. The item must be palletized in accordance with DLA packaging requirements, shipped via the fastest traceable means excluding parcel post, and delivered FOB destination to Fort Stewart, Georgia within 20 days of contract award. The required delivery date is July 24, 2026, with zero variance allowed in quantity. The solicitation number is SPE2DP-26-T-4278, with a response deadline of August 3, 2026, and the North American Industry Classification System code is 325412. Government use designation and shipping instructions include specific codes and identifiers for logistics and tracking purposes.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
CHLORINE TEST REAGEThe contract specifies the procurement of Chlorine Test Reagent, a DPD total chlorine reagent supplied in 100 powder pillows, each designed for a 10 mL sample size, with the unit of issue being one package containing 100 pillows. The item is identified by NSN 6550-01-460-7597 and must meet stringent technical and quality requirements referenced from the DLA Master List of Technical and Quality Requirements. It is subject to DLA packaging standards, including commercial packaging for all medical acquisitions, requiring each unit to be sealed in a protective container and shipped in suitable exterior packaging to ensure safe delivery at the lowest carrier rate. All markings must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must include the date of manufacture, expiration or retest date, and the contract or lot number in accordance with the latest revision of MMS1C. The item is classified as a TYPE I (CODE S) with a mandatory 60-month shelf life that is non-extendable, and no more than eight months may have passed between the date of manufacture and the date of delivery to the government. The solicitation, issued under SPE2DS-26-T-269Y on July 26, 2026, requires delivery within 20 days after order and is managed by the Department of Defense’s Medical Supply Chain, with Seth Tootell as the primary point of contact.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LACRINGER'S INJECTION, LACTATED, USP in 500 mL units, packaged 24 per case, is procured under contract SPE2DP-26-T-4281 with a total quantity of two cases, delivered FOB destination within 20 days. Each case must contain intact, sealed unit containers protecting the product from damage, with exterior shipping containers compliant with commercial standards and marked according to Medical Marking Standard No. 1, replacing all references to MIL-STD-129. The item has a non-extendable shelf life of 18 months, requiring at least 15 months of remaining shelf life upon delivery to the first government activity, and must be stored at controlled room temperature not exceeding 25°C. The product is regulated by the FDA, with supplier and manufacturer details including B. B Braun Medical Inc. and Baxter Healthcare Corp, identified by NDC 00264-7750-10 and part numbers L7501 and 2B2323Q. Packaging and quality requirements adhere to the DLA Master List of Technical and Quality Requirements, with all procurement governed by DLA packaging and medical acquisition standards. The National Stock Number is 6505014623022, and the unit of issue is PG, where one PG equals 24 units. Inspection and acceptance occur at the destination, with no variance allowed in quantity. Delivery is to Fort Bliss, Texas, with primary point of contact Daniel Porter at DLA Troop Support.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride 0.9% Injection USP in 100 mL units is being procured under solicitation SPE2DP-26-T-4290 with a required delivery within five days to Fort Bragg, North Carolina, delivered FOB destination. The item is supplied by Baxter Healthcare under NDC 00338-0553-18 and part number 2B0043, packaged as one package containing 80 units, with no variance allowed in quantity. The product is regulated by the FDA and must comply with all federal medical procurement standards, including the Medical Marking Standard No. 1, which supersedes MIL-STD-129 and governs labeling and packaging requirements to ensure safe handling and transport. The item is classified as a TYPE I (CODE M) with a non-extendable shelf life of 24 months from the date of manufacture, and all packaging must meet commercial standards while ensuring protection against damage and breakage during transit. The contract requires compliance with DLA’s Master List of Technical and Quality Requirements, and any referenced technical or quality specifications are incorporated by reference from the official DLA website. The acquisition is subject to the Covered Defense Information provisions, and the contracting official must submit an EBS referral for FDA-regulated product confirmation, including full manufacturer and bidder details. The unit of issue is PG (package), with a total quantity of one PG, and the item’s NSN is 6505013841365.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
APPLICATOR, SILVER NITRThe applicator is a topical medical device containing a fused mixture of 75% silver nitrate and 25% potassium nitrate, designed for single-use application and classified as prescription-only. Each applicator measures six inches or 1.524 centimeters and is packaged in containers of 100 units, requiring storage in a dark, dry, room-temperature environment away from organic or oxidizable materials. The item has a non-extendable shelf life of 24 months and is subject to stringent hazardous material handling standards, including mandatory submission of a current Material Safety Data Sheet via DLA’s designated email and physical inclusion with every shipment. Packaging must comply with 49 CFR and ICAO technical regulations, and the item is regulated by the FDA, requiring official referral for confirmation prior to procurement. It is identified by NSN 6505-00-299-9672 and falls under solicitation SPE2DP-26-T-4291, with a required delivery within five days of award and procurement governed by Department of Defense protocols and the DLA Master List of Technical and Quality Requirements.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride Injection, USP, 0.9% in 1000 mL plastic bags, is procured under solicitation SPE2DP-26-T-4286 with a requirement for latex-free packaging and compliance with DLA’s packaging and quality standards. The product must be supplied in unit packages of 12 bags per package, shipped in commercial-grade exterior containers meeting Medical Marking Standard No. 1, which supersedes MIL-STD-129, and each unit must be sealed to prevent damage. The item has a non-extendable shelf life of 30 months and must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from excessive heat and freezing. The contract specifies a firm fixed quantity of three packages (36 bags total) to be delivered FOB destination within 20 days, with zero variance allowed in quantity and inspection and acceptance occurring at the delivery point. The NDC code 00264-5802-00 and 00990-7983-09 are referenced, associated with B. Braun Medical Inc. and ICU Medical Sales, Inc., and the item is regulated by the FDA. All packaging, marking, and documentation must conform to DLA’s Master List of Technical and Quality Requirements, and the contracting official must submit a referral in EBS for bidder and manufacturer verification. The NSN is 6505-01-330-6269, and the unit of issue is PG, with total contract value at $3.00 per package.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 424210
New
DIBBS
DANTROLENE SODIUM FORDantrolene Sodium for Injection, USP, 250mg per vial, is procured under contract SPE2DP-26-T-4289 with a total quantity of six vials, each containing 20 mL. The item is regulated by the FDA and requires strict adherence to packaging, labeling, and storage specifications. Each vial must be sealed in a protective unit container and packed in commercial shipping containers suitable for safe transport by common carriers at the lowest rate, with delivery required FOB destination within five days. Packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must include the NSN, manufacturer and CAGE code, contract number, lot number, date of manufacture, and expiration date. The unopened product must be stored at controlled room temperature between 20 to 25 degrees Celsius and protected from light. The item has a non-extendable shelf life of 24 months, designated as a TYPE I (CODE M) item under RS001. Only approved manufacturers—Cardinal Health, AmerisourceBergen, and Eagle Pharmaceuticals—are listed with matching NDC codes. All packaging must conform to the DLA Master List of Technical and Quality Requirements, which take precedence over commercial standards like ASTM D3951. The material is not considered hazardous under FED-STD-313 and must be shipped via the fastest traceable means, excluding parcel post, to the designated delivery point at Fort Bragg, North Carolina. The required delivery date is July 27, 2026, and the solicitation response deadline is August 3, 2026.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOLBenzocaine and Menthol Lozenge, marketed as CEPACOL EXTRA STRENGTH SORE THROAT HONEY LEMON LOZENGES, contains 15 mg of benzocaine and 2.6 mg of menthol per lozenge as an oral pain reliever, packaged in units of 16 lozenges and requiring storage at 20–25 °C (68–77 °F) with protection from humidity. The product is procured under solicitation SPE2DP-26-T-4285 by the Department of Defense through DLA Troop Support, with supply chain compliance governed by Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a protective container, and shipments must be packed in commercial exterior containers designed for safe, low-cost transport to the delivery point. The item has a non-extendable shelf life of 36 months (TYPE I, CODE Q) and is subject to strict packaging and marking protocols per DLA packaging requirements, including palletization standards and commercial packaging specifications. The NSN 6505017081449 applies to both contract lines, with total quantities of 6 and 25 packages respectively, both subject to zero variance in delivery quantity. Delivery is FOB destination within five days of requirement, with no parcel post permitted; shipments must use traceable freight methods to specified military locations at Fort Bragg, North Carolina. The products are sourced from Reckitt Benckiser LLC and RB Health US LLC under NDC 638240732-16, and all items must meet technical and quality standards referenced in the DLA Master List of Technical and Quality Requirements. The contract designates destination as both inspection and acceptance point, with no tolerance for deviation from quantity or packaging specifications. Government use codes and logistics identifiers are embedded for internal tracking, and the original required delivery dates are July 28 and 29, 2026, respectively. The solicitation response deadline is August 3, 2026, and the procurement is classified under NAICS code 325411 for pharmaceutical preparation manufacturing.
Medicinal and Botanical Manufacturing

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 424210
New
DIBBS
LIDOCAINE GELLidocaine 4% Gel with Aloe Vera is a topical pain relief product intended for use on sunburn, scrapes, and insect bites, formulated to be fragrance-free and packaged in 4OZ (118ML) containers. Each unit must be sealed in a protective container that prevents damage or breakage, and all units must be packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost to the designated point of delivery. The product has a mandatory 24-month shelf life, with no more than three months allowed to have passed from the date of manufacture to the date of government delivery, and it is classified as a Type 01 shelf life item. Storage must not exceed 100 degrees Fahrenheit. Packaging and marking must strictly comply with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129, and details for this standard are available through DLA Troop Support. The product is identified by NSN 6505-01-695-6400 and part number 814660011517, with 12 containers per box as the unit of issue. Delivery is required within five days of contract award, FOB destination, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. Shipments must be sent via the fastest traceable means, excluding parcel post, to the designated military facility at Fort Bragg, North Carolina. The solicitation number is SPE2DP-26-T-4273, with a required delivery date of July 27, 2026, and the supplier is United Spirit of America Inc.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATESUMATRIPTAN SUCCINATE TABLETS, 100MG, are supplied in bottles of nine tablets and are indicated for the acute treatment of migraines with or without aura in adults. The product must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light. It has a non-extendable shelf life of 24 months as a TYPE I (CODE M) item, with strict compliance required to the FDA regulatory framework and DLA packaging and marking standards including MIL-STD-2073-1E and MIL-STD-129. The item is sourced from MYLAN PHARMACEUTICALS INC and GOLDEN STATE MEDICAL SUPPLY, INC., identified by NDC codes 00378-5632-59 and 51407-0013-09 respectively. The contract requires delivery within five days of award to JBER, Alaska, FOB destination with zero variance in quantity and inspection and acceptance occurring at the delivery point. Packaging must adhere to DLA’s RP001 requirements and Medical Marking Standard No. 1, with all labeling and palletization conforming to federal guidelines. The solicitation number is SPE2DP-26-T-4284, with a required delivery date of July 28, 2026, and a submission deadline of August 3, 2026. Government procurement is governed by DLA’s Master List of Technical and Quality Requirements, and all bidders must be verified through the EBS referral process with full manufacturer and product details submitted for confirmation.
Medicinal and Botanical Manufacturing

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325611
New
DIBBS
HAND SANITIZERThe contract specifies the procurement of PURELL hand sanitizer in 3 FL OZ bottles with special side grips for one-handed dispensing, designed to withstand extreme temperatures. Each unit of issue is a package of 24 units, and the product must be stored at controlled room temperature. The item is identified by NSN 6508-01-535-5409 and manufacturer part number NDC21749-0965-03, supplied by GOJO INDUSTRIES INC. It is classified as a TYPE I (CODE Q) shelf-life item with a non-extendable shelf life of 36 months. The product must comply with the latest Medical Marking Standard No. 1 and DLA packaging requirements, including MIL-STD-2073-1E for packaging data. As a regulated medical device under FDA oversight, the supplier must submit Safety Data Sheets and Hazard Communication Standard labels compliant with 29 C.F.R. 1910.1200 prior to award, and ensure employee training on updated hazard communication protocols. The item is subject to zero variance in quantity, with delivery required FOB destination within 20 days, and inspection and acceptance occur at the delivery point. The contract references DLA’s Master List of Technical and Quality Requirements and mandates adherence to all applicable federal standards for hazardous materials labeling and documentation.
Soap and Other Detergent Manufacturing

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details